MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas

BACKGROUND: Uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer (HLRCC) patients are driven by fumarate hydratase (FH) inactivation or occasionally by mediator complex subunit 12 (MED12) mutations. The aim of this study was to analyse whether MED12 mutations and FH inactivation a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kämpjärvi, Kati, Mäkinen, Netta, Mehine, Miika, Välipakka, Salla, Uimari, Outi, Pitkänen, Esa, Heinonen, Hanna-Riikka, Heikkinen, Tuomas, Tolvanen, Jaana, Ahtikoski, Anne, Frizzell, Norma, Sarvilinna, Nanna, Sjöberg, Jari, Bützow, Ralf, Aaltonen, Lauri A, Vahteristo, Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984459/
https://www.ncbi.nlm.nih.gov/pubmed/27187686
http://dx.doi.org/10.1038/bjc.2016.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984459/
https://www.ncbi.nlm.nih.gov/pubmed/27187686
http://dx.doi.org/10.1038/bjc.2016.130

Ejemplares similares